CELLDEX THERAPEUTICS INC NEW - COM (CLDX)

CUSIP: 15117B103

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
54,402,743
Share change
-18,242,582
Total reported value
$27,392,430
Put/Call ratio
407%
Price per share
$0.50
Number of holders
89
Value change
-$42,858,522
Number of buys
33
Number of sells
79

Quarterly Holders Quick Answers

What is CUSIP 15117B103?
CUSIP 15117B103 identifies CLDX - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM (CLDX) as of Q2 2018

As of 30 Jun 2018, CELLDEX THERAPEUTICS INC NEW - COM (CLDX) was held by 89 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,402,743 shares. The largest 10 holders included KLP Enterprises, LLC, Meditor Group Ltd, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., DEUTSCHE BANK AG\, MILLENNIUM MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, and TWO SIGMA INVESTMENTS, LP. This page lists 89 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.